As ccRCC advances from early to late stages, there is a discernible increase in the population of terminally exhausted CD8+ T cells, accompanied by a concomitant decrease in cytotoxic CD8+ T cells. The gene discussed is CD8A; the disease is nonpapillary renal cell carcinoma.